SEC Form 4 · accession 0001209191-15-051259
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Garner
Officer — CFO and Chief Business Officer
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 10:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2015 | P | 2,000 | $8.50 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.